Literature DB >> 25973792

Permeation of proteins, oligonucleotide and dextrans across ocular tissues: experimental studies and a literature update.

Silvia Pescina1, Paolo Govoni2, Maxim Antopolsky3, Lasse Murtomäki4, Cristina Padula1, Patrizia Santi1, Sara Nicoli1.   

Abstract

Proteins and oligonucleotides represent powerful tools for the treatment of several ocular diseases, affecting both anterior and posterior eye segments. Despite the potential of these compounds, their administration remains a challenge. The last years have seen a growing interest for the noninvasive administration of macromolecular drugs, but still there is only little information of their permeability across the different ocular barriers. The aim of this work was to evaluate the permeation of macromolecules of different size, shape and charge across porcine ocular tissues such as the isolated sclera, the choroid Bruch's membrane and the cornea, both intact and de-epitelialized. Permeants used were two proteins (albumin and cytochrome C), an oligonucleotide, two dextrans (4 and 40 kDa) and a monoclonal antibody (bevacizumab). Obtained data and its comparison with the literature highlight the difficulties in predicting the behavior of macromolecules based on their physicochemical properties, because the interplay between the charge, molecular radius and conformation prevent their analysis separately. However, the data can be of great help for a rough evaluation of the feasibility of a noninvasive administration and for building computational models to improve understanding of the interplay among static, dynamic and metabolic barriers in the delivery of macromolecules to the eye.
© 2015 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  diffusion; in vitro models; macromolecular drug delivery; monoclonal antibody; oligonucleotides; passive diffusion/transport; permeability; proteins

Mesh:

Substances:

Year:  2015        PMID: 25973792     DOI: 10.1002/jps.24465

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Ex vivo permeation of erythropoietin through porcine conjunctiva, cornea, and sclera.

Authors:  Ana Paula Resende; Beatriz Silva; Berta São Braz; Telmo Nunes; Lídia Gonçalves; Esmeralda Delgado
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

2.  Effects of D-serine treatment on outer retinal function.

Authors:  Nathalia Torres Jimenez; Robert F Miller; Linda K McLoon
Journal:  Exp Eye Res       Date:  2021-08-20       Impact factor: 3.770

3.  The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant.

Authors:  Martina Kodetova; Radka Hobzova; Jakub Sirc; Jiri Uhlik; Katerina Dunovska; Karel Svojgr; Ana-Irina Cocarta; Andrea Felsoova; Ondrej Slanar; Martin Sima; Igor Kozak; Pavel Pochop
Journal:  Pharmaceutics       Date:  2022-04-20       Impact factor: 6.525

4.  Controllable continuous sub-tenon drug delivery of dexamethasone disodium phosphate to ocular posterior segment in rabbit.

Authors:  Xuetao Huang; Shaogang Liu; Yezhen Yang; Yiqin Duan; Ding Lin
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Anti-Apoptotic Gene Delivery with cyclo-(d-Trp-Tyr) Peptide Nanotube via Eye Drop Following Corneal Epithelial Debridement.

Authors:  Yu-Hsing Lee; Shwu-Fen Chang; Jiahorng Liaw
Journal:  Pharmaceutics       Date:  2015-07-17       Impact factor: 6.321

Review 6.  Systemic side effects of eye drops: a pharmacokinetic perspective.

Authors:  Andre Farkouh; Peter Frigo; Martin Czejka
Journal:  Clin Ophthalmol       Date:  2016-12-07

7.  Preliminary Investigation on Simvastatin-Loaded Polymeric Micelles in View of the Treatment of the Back of the Eye.

Authors:  Silvia Pescina; Fabio Sonvico; Adryana Clementino; Cristina Padula; Patrizia Santi; Sara Nicoli
Journal:  Pharmaceutics       Date:  2021-06-09       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.